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Exercise Physiology
Ethnic Differences in Physiological Cardiac Adaptation to
Intense Physical Exercise in Highly Trained Female Athletes
J. Rawlins, MRCP; F. Carre, PhD; G. Kervio, PhD; M. Papadakis, MRCP; N. Chandra, MRCP;
C. Edwards, MRCP; G.P. Whyte, PhD; S. Sharma, MD
Background—Ethnicity is an important determinant of cardiovascular adaptation in athletes. Studies in black male athletes
reveal a higher prevalence of electric repolarization and left ventricular hypertrophy than observed in white males; these
frequently overlap with those observed in cardiomyopathy and have important implications in the preparticipation
cardiac screening era. There are no reports on cardiac adaptation in highly trained black females, who comprise an
increasing population of elite competitors.
Methods and Results—Between 2004 and 2009, 240 nationally ranked black female athletes (mean age 2164.6 years old)
underwent 12-lead ECG and 2-dimensional echocardiography. The results were compared with 200 white female
athletes of similar age and size participating in similar sports. Black athletes demonstrated greater left ventricular wall
thickness (9.261.2 versus 8.661.2 mm, P,0.001) and left ventricular mass (187.2642 versus 172.3642 g, P50.008)
than white athletes. Eight black athletes (3%) exhibited a left ventricular wall thickness .11 mm (12 to 13 mm)
compared with none of the white athletes. All athletes revealed normal indices of systolic and diastolic function. Black
athletes exhibited a higher prevalence of T-wave inversions (14% versus 2%, P,0.001) and ST-segment elevation (11%
versus 1%, P,0.001) than white athletes. Deep T-wave inversions (20.2 mV) were observed only in black athletes and
were confined to the anterior leads (V1 through V3).
Conclusions—Systematic physical exercise in black female athletes is associated with greater left ventricular hypertrophy
and higher prevalence of repolarization changes than in white female athletes of similar age and size participating in
identical sporting disciplines. However, a maximal left ventricular wall thickness .13 mm or deep T-wave inversions
in the inferior and lateral leads are rare and warrant further investigation. (Circulation. 2010;121:1078-1085.)
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Regular participation in intense sporting activity is asso-ciated with physiological electric, structural, and func-
tional cardiac modifications1 that frequently manifest on the
ECG,2,3 2-dimensional echocardiogram,4–6 and exercise
stress test.7 The magnitude of such adaptations is largely
determined by demographic factors and sporting disci-
pline.2–6 Generally, extreme manifestations of the athlete’s
heart are confined to adult males participating in endurance
sporting disciplines; in rare instances, these overlap with
manifestations observed in individuals with hypertrophic
cardiomyopathy (HCM).4 In contrast, white female athletes
do not exhibit ECG or echocardiographic changes that may
be regarded as representing HCM.8,9
Editorial see p 1066
Clinical Perspective on p 1085
There is increasing evidence that an athlete’s ethnic origin
may have a significant impact on the cardiovascular response
to exercise. Recent studies examining cardiac adaptation in
African/Afro-Caribbean (black) male athletes demonstrated
that black male athletes develop more striking repolarization
changes on the ECG and exhibit a greater magnitude of left
ventricular hypertrophy (LVH) than white male athletes of
similar age and size participating in identical sports.10,11
Indeed, up to 25% of black athletes exhibit either repolariza-
tion changes or LVH that overlaps with morphologically mild
HCM.11 These observations are relevant to recent recommen-
dations attempting to mandate cardiovascular screening
among elite sportsmen, particularly in countries such as the
United States and the United Kingdom, where black athletes
represent a substantial fraction of athletes competing at the
national level.
Current standardized ECG guidelines that are used to
differentiate between a normal ECG and one that is poten-
tially indicative of cardiac pathology are derived from the
white athletic population and raise the potential for false
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diagnoses and unnecessary disqualification in black ath-
letes.12,13 There are no data relating to cardiovascular adap-
tation in black female athletes, who comprise an increasing
proportion of athletes representing Western countries at
international sporting events. However, this unstudied group
may potentially be subject to similar issues as black male
athletes. The aim of the present study was to examine the
ECG and echocardiographic appearances in highly trained
national-level black female athletes to facilitate clinical de-
cisions relating to future preparticipation cardiovascular
screening.
Methods
Setting
The study was part of a collaborative research program between the
United Kingdom and France since 2006 to characterize cardiovas-
cular adaptation in black athletes. Neither country has a nationally
sponsored cardiovascular screening program for athletes; however,
in the United Kingdom, certain sporting bodies, including the
International Olympic Committee,13 football associations (Union of
European Football Associations, Fe´de´ration Internationale de Foot-
ball),14 Lawn Tennis Association, and the International Rugby
Board, have privately funded mandatory screening for all athletes
competing at the national level.
Athletes not affiliated with these organizations but participating in
the Commonwealth Games also undergo mandatory preparticipation
screening. Most UK screenings are supervised by the senior author
(SS) at national sporting training camps, the Olympic Medical
Institute, King’s College Hospital, and University Hospital Lew-
isham. In France, all athletes participating at the national level
undergo mandatory preparticipation cardiovascular screening; the
majority of screenings are supervised by the second author (FC) at
the University of Rennes.
Subjects
Between 2006 and 2009, 440 consecutive nationally ranked female
athletes (240 [55%] black) underwent assessment with a health
questionnaire, physical examination, ECG, and 2-dimensional echo-
cardiography as part of a standard preparticipation cardiac evalua-
tion. All athletes provided written consent for the evaluation. Ethics
approval was obtained from the University Hospital Lewisham
Research Ethics Committee. Black ethnicity was determined through
self-reported questionnaires that included terms such as black Afri-
can, black Afro-Caribbean, black British, and black French.
Twelve-Lead ECG
A standard ECG was performed with the subject in a supine position
with a Philips Pagewriter Trim III (Philips, Bothell, Wash) recorder
as described previously.15 Heart rate and QRS axis were calculated.
P-, Q-, R-, S-, and T-wave voltages; ST segments; QRS duration; PR
interval; and QT interval were measured in each lead with calipers.
The QT interval was corrected for the heart rate by use of the Bazett
formula.16 Electrocardiographic LVH was defined with the
Sokolow-Lyon voltage criterion.17 T-wave inversions in 2 or more
contiguous leads were considered significant, other than in leads V1
and III.
Transthoracic Echocardiography
A 2-dimensional echocardiogram was conducted by 1 of 3 experi-
enced cardiologists (including 2 authors: J.R. and G.K.) using GE
Vivid I (General Electric, Tirat Carmel, Israel), Philips Sonos 7500,
or Philips CPX50 cardiac ultrasound equipment. Standard views of
the heart were obtained and analyzed according to the protocol
specified by the European Society of Echocardiography.18 Left
ventricular (LV) wall thickness (LVWT) was measured in the
2-dimensional parasternal short axis, at the levels of the mitral valve
and papillary muscles, the greatest measurement being defined as the
maximal LVWT. LV mass (LVM) was calculated with the formula
of Devereux.19 LV ejection fraction was calculated from LV vol-
umes by Simpson’s rule.20 Assessment of diastolic function included
traditional pulsed-wave Doppler across the mitral valve21 and tissue
Doppler velocity imaging22 of the septal and lateral mitral valve
annulus. Echocardiographic studies were saved to compact discs as
numeric files to generate anonymity, and cardiac measurements were
repeated independently by an experienced cardiologist (S.S.) blinded
as to the identity of the athlete.
Further Evaluation
Athletes with LVH (LVWT .11 mm) or deep (more than 20.2 mV)
T-wave inversions in 2 contiguous leads were investigated further
with an exercise test, 48-hour Holter monitor, and cardiac magnetic
resonance scan to investigate the broader phenotypic features of
HCM.
Exercise Stress Testing
An upright treadmill stress test was performed with the standard
Bruce protocol.23 ECGs and blood pressure (BP) were recorded at
1-minute intervals. Athletes were exercised to volitional exhaustion
and assessed specifically for the development of ischemic changes,
BP response,24 and arrhythmias.
Forty-Eight-Hour ECG Monitoring
Forty-eight-hour ambulatory ECG monitoring was performed to
check specifically for supraventricular and ventricular
tachyarrhythmias.25 Athletes were encouraged to continue daily
activities, including exercise, during the investigation.
Cardiac Magnetic Resonance Imaging
Cardiac magnetic resonance imaging was performed with a Siemens
Sonata 1.5T system (Erlangen, Germany) with steady-state, free-
precession breath-hold cines (time to echo/repetition time 1.6/3.2 ms,
flip angle 60°) in long-axis planes and sequential 7-mm short-axis
slices (3-mm gap) from the atrioventricular ring to the apex. Late
gadolinium enhancement images were acquired 10 minutes after
intravenous administration of gadolinium-DTPA (Schering,
0.1 mmol/kg) in identical short-axis planes with an inversion-
recovery gradient echo sequence. Inversion times were adjusted to
null normal myocardium (typically 320 to 440 ms; pixel size
1.731.4 mm). Late gadolinium enhancement images were phase-
swapped to exclude artifact. Ventricular volumes and function were
measured for both ventricles by standard techniques26,27 and ana-
lyzed with semiautomated software (CMR tools, Cardiovascular
Imaging Solutions, London, United Kingdom). All volumes and
masses were indexed for age and body surface area.
Statistical Analysis
Data are expressed as mean6SD. Statistical analyses were per-
formed with unpaired Student t test and Fisher exact test, calculated
from a 232 contingency table.
For continuous variables, a stepwise multivariable linear regres-
sion model was constructed to assess the relationship between
LVWT and LVM as dependent variables, with age, height, weight,
body surface area, ethnicity, and hours trained as predictors. For
binary variables, a binary logistic regression model was constructed
to assess any relationship between T-wave inversions or ST-segment
elevation as dependent variables and age, height, weight, body
surface area, number of hours trained, ethnicity, maximal LVWT,
and LV end-diastolic cavity diameter as independent variables. SPSS
version 12 was used for all statistical analyses. P,0.05 was
considered significant and was essential for predictors to enter and
remain in multivariable regression models.
Results
Subjects
All athletes were asymptomatic and normotensive (BP #120/
80 mm Hg), and none volunteered a family history of
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cardiomyopathy or premature sudden cardiac death. Athletes
were of similar age and size and competed in a similar range
of sporting disciplines. The majority of black athletes
(n5169; 70%) and white athletes (n5140; 70%) were from
the United Kingdom (Table 1).
LV Dimensions
Black athletes demonstrated a greater maximal LVWT than
white athletes (9.261.2 versus 8.661.2 mm, P,0.001),
which amounted to a 7% difference between the 2 groups
(Table 2). Calculated LVM was also greater in black athletes
than in white athletes (187.2642 versus 172.3642 g,
P50.008).
Black athletes also exhibited a greater left atrial diameter
than white athletes (35.364.7 versus 32.564.8 mm,
P,0.001). There were no differences between the ethnic
groups with respect to LV cavity size and aortic root
diameter. Twenty black athletes (8%) and 12 white athletes
(6%) revealed an enlarged (.54 mm) LV end-diastolic
cavity. All athletes had normal indices of systolic and
diastolic function.
LVH in Female Athletes
The distribution of maximal LVWT is shown in Figure 1.
None of the white athletes demonstrated a maximal LVWT of
.11 mm. In contrast, 8 black athletes (3.3%) exhibited a
maximal LVWT .11 mm (12 to 13 mm) and were consid-
ered to exhibit LVH. The demographic, echocardiographic,
and ECG features of the 8 black athletes with LVH are shown
in Table 3.
The pattern of LVH in all of the black female athletes was
homogeneous, with a difference of ,2 mm between adjacent
segments. All athletes with LVH exhibited a normal LV
diastolic cavity size (Table 3). None of the athletes with LVH
exhibited dynamic LV outflow obstruction.28 There were no
differences in age (21.561.9 versus 21.364.6 years,
P50.92), height (1.6960.11 versus 1.7260.09 m, P50.496),
weight (75611 versus 67610.9 kg, P50.12), or body surface
area (1.8560.19 versus 1.7960.17 m2, P50.45) between
black athletes with LVH and those without.
Table 1. Demographics of Black and White Athletes
Black Athletes
(n5240)
White Athletes
(n5200) P
Age, y 2164.6 (14, 35) 2064.0 (14, 35) 0.18
Weight, kg 66.1611.6 (39, 106) 64.168.8 (45, 92) 0.06
Height, m 1.7168.4 (1.50, 1.92) 1.7067.7 (1.50, 1.91) 0.07
BSA, m2 1.7860.17 (1.31, 2.21) 1.7360.18 (1.33, 1.96) 0.10
Resting BP,
mm Hg
110619 (120, 80) 111613 (120, 80) 0.80
Training h/wk 13.763.4 (8, 24) 14.466.1 (8, 36) 0.41
Sporting discipline, %
Athletics* 25 23 0.58
Basketball 20 18 0.63
Football (soccer) 16 20 0.26
Netball 18 18 1.00
Martial arts 13 11 0.56
Other 8† 10‡ 0.50
LDR n58 n510
Fencing n53 n52
Handball n53 n52
Weightlifting n53 n52
Hockey n52 n54
BSA indicates body surface area; LDR, long-distance running.
Data are expressed as mean6SD (limits).
*Track and field events.
†n519.
‡n520.
Table 2. Comparison of Echocardiographic Cardiac
Dimensions Between Black and White Female Athletes
Black Athletes
(n5240)
White Athletes
(n5200) P
Ao, mm 27.262.9 (23, 38) 26.463.5 (17, 33) 0.21
LA, mm 35.364.7 (21, 41) 32.564.8 (25, 47) ,0.0001
LVED, mm 48.663.9 (39, 60) 48.263.5 (40, 62) 0.93
LVES, mm 27.364.0 (21, 44) 30.564.7 (20, 44) 0.47
IVSd, mm 9.061.3 (6, 13) 8.461.2 (6, 11) ,0.001
PTWD, mm 8.761.3 (6, 12) 8.461.2 (6, 11) 0.14
Max LVWT,
mm
9.261.2 (6, 13) 8.661.2 (6, 11) ,0.001
LVM, g 187.2642 (95, 322) 172.3642 (86, 293) 0.008
E wave, m/s 0.8960.2 (1.36, 0.6) 0.9060.2 (1.33, 0.53) 0.49
A wave, m/s 0.4160.1 (1.1, 0.2) 0.4460.1 (0.9, 0.2) 0.076
E/A ratio 2.360.8 (5.5, 1.1) 2.260.8 (5.5, 1.1) 0.15
E9, m/s 0.2260.03 (0.25, 0.13) 0.2360.03 (0.28, 0.17) 0.40
A9, m/s 0.0760.03 (0.16, 0.02) 0.0660.03 (0.13, 0.03) 0.43
E:E9 4.4160.71 (5.61, 2.30) 4.4660.74 (5.55, 1.96) 0.39
EF, % 6766.7 (41, 78) 6666.9 (44, 76) 0.48
Ao indicates aortic annulus diameter; LA, left atrial diameter; LVED, LV
end-diastolic diameter; LVES, LV end-systolic diameter; IVSd, maximal LV
septal wall thickness in end diastole; PTWD, LV posterior wall thickness in end
diastole; Max LVWT, maximal LVWT in end diastole; E wave, early diastolic
mitral valve peak inflow velocity; A wave, late diastolic mitral valve inflow peak
velocity; E9, early diastolic annular peak velocity (lateral mitral annulus); A9, late
annular diastolic peak velocity (lateral mitral annulus); E:E9, ratio of peak early
diastolic mitral inflow velocity to peak early diastolic mitral annular velocity;
and EF, ejection fraction.
Data are expressed as mean6SD (limits).
Figure 1. Histogram showing the distribution of maximal LVWT
in black (black bars) and white (gray bars) female athletes. Three
percent of black athletes demonstrated a maximal LVWT
.11 mm compared with none of the white athletes.
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Determinants of LVH
The results of a multivariable linear regression model that
assessed the relationship between maximal LVWT and age,
body surface area, ethnicity, and number of hours trained
demonstrated that ethnicity was the strongest independent
predictor of maximal LVWT (b50.263, CI 0.29 to 0.855,
P,0.001), with age being the only other significant factor
(b520.155, CI 20.07 to 0.01, P50.006). There was no
relationship between sporting discipline and LVH.
Reliability of LVWT Measurements in Athletes
The averaged coefficients of variation between intraobserver
and interobserver reliability for maximal LVWT measure-
ments were 4% and 6.2%, respectively.
ECG Findings
Black athletes demonstrated a greater PR interval than white
athletes, whereas white athletes revealed a slightly greater
QRS duration than black athletes. There were no significant
differences between black athletes and white athletes with
respect to QRS axis, QT interval, voltage criteria for LVH,
right or left atrial hypertrophy, or incomplete right bundle
branch (Table 4). None of the athletes exhibited pathological
Q waves (.40 ms wide or exceeding in depth 25% of the
height of the preceding R wave), ST-segment depression, left
bundle-branch block, or epsilon waves.
Repolarization Anomalies
Black athletes demonstrated a higher prevalence of ST-
segment elevation than white athletes (n526 [11%]) versus
n52 [1%]; P,0.001). Black athletes also exhibited a higher
prevalence of contiguous T-wave inversions than white ath-
letes (n534 [14%]) versus n54 [2%]; P,0.001; Figure 2). In
black athletes, T-wave inversions were confined to leads V1
through V3 and exceeded 20.2 mV (deep T-wave inversions)
in 6 individuals (2%; Figure 3D). In contrast, white athletes
only showed T-wave inversions in leads III and aVF, and
none exhibited deep T-wave inversions.
Determinants of Repolarization Anomalies
The results of a binary logistic regression model, with the
dependent variable being the presence of T-wave inversions,
demonstrated that black ethnicity was the only significant
independent predictive factor (b51.94, SE50.417,
P50.003). Black ethnicity was also the strongest independent
predictive factor (b51.29, SE5349, P,0.001) when ST-
segment elevation was used as a dependent variable in the
model, with athlete height having a weak additional effect
(b50.042, SE50.021, P50.043).
Correlation Between ECG and Echocardiogram
There was a weak correlation between the presence of
T-wave inversions and magnitude of LVWT and LVM in
both groups (maximal LVWT: P50.039; LVM: P50.041).
However, there were no significant differences in absolute
values of maximal LVWT between athletes with T-wave
inversions and those without in either group (black athletes:
P50.12; white athletes: P50.07). The identification of
T-wave inversions did not predict the presence of LVH or
increased LV cavity size. There was no relationship between
the presence of Sokolow-Lyon voltage criteria for LVH on
the ECG and maximal LVWT or LVM (maximal LVWT:
P50.278; LVM: P50.408).
Table 3. Demographic, Echocardiographic, and ECG Features of Black Athletes With LVH
Age,
y
BSA,
m2 Sport
LVED,
mm
LVES,
mm
LAD,
mm
MLVWT,
mm
LVM,
g
EF,
%
E,
m/s
A,
m/s E:A
E9,
m/s E:E9
T-Wave
Inversion
(Leads) LAE LVH
20 1.62 Judo 53 35 30 12 236 64 1.00 0.47 2.1 0.17 5.9 None No No
20 2.01 Netball 48 34 32 12 276 65 0.8 0.4 2 0.15 5.3 None Yes No
20 1.82 Sprinting 50 37 36 13 329 66 0.8 0.42 1.90 0.22 3.6 None No Yes
21 1.98 Basketball 51 37 36 13 260 68 0.8 0.39 2.1 0.16 5.0 None No No
22 1.71 Football 45 26 32 13 279 70 0.9 0.38 2.3 0.19 4.7 V1, V2 No No
22 2.02 Netball 51 40 37 13 322 65 0.6 0.42 1.4 0.16 3.7 V1, V2 No No
23 1.87 Football 48 33 31 12 276 67 0.72 0.41 1.8 0.21 3.4 None No Yes
24 1.77 Weightlifting 42 24 37 13 211 72 0.91 0.42 2.2 0.21 4.3 None No No
BSA indicates body surface area; LVED, LV end-diastolic diameter; LVES, LV end-systolic diameter; LAD, left atrial diameter; MLVWT5maximal LVWT; EF, ejection
fraction; LAE, voltage criterion for left atrial enlargement; and LVH, voltage criterion for LVH.
Table 4. Comparison of ECG Parameters Between Black and
White Female Athletes
Black Athletes
(n5240)
White Athletes
(n5200) P
Heart rate, bpm 6168.3 (44, 85) 6069.5 (35, 85) 0.26
PR interval, ms 162625 (112, 246) 149623 (88, 228) ,0.001
QRS duration, ms 84610 (43, 105) 87610 (66, 120) 0.0072
QT interval, ms 400632 (330, 475) 415633 (290, 447) 0.17
QTc (Bazett’s), ms 404642 (358, 465) 407641 (285, 474) 0.28
Axis, degrees 67614 (32, 89) 65632 (226, 129) 0.66
LAE, % 12.5 10 0.45
RAE, % 5 4 0.65
LVH voltage, % 8 12 0.16
Partial RBBB, % 14 14 0.89
QTc indicates corrected QT interval; LAE, voltage criterion for left atrial
enlargement; RAE, voltage criterion for right atrial enlargement; and RBBB,
right bundle-branch block.
Data are expressed as mean6SD (limits) or percentages, as appropriate.
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Subsequent Investigations
Twelve black athletes (exhibiting LVH and/or deep
T-wave inversions) underwent an exercise stress test,
48-hour Holter monitoring, and a cardiac magnetic reso-
nance scan. None of the 12 athletes demonstrated any
phenotypic features of HCM or any other form of cardio-
myopathy. Specifically, none of the 12 athletes exhibited
flat BP responses to exercise,24 .1000 ventricular extra-
systoles/nonsustained ventricular tachycardia,25 or late
gadolinium enhancement (to indicate myocardial fibro-
sis),29 apical hypertrophy,29 and right ventricular wall-
motion abnormalities,30 on exercise testing, the 48-hour
Holter monitor, and the cardiac magnetic resonance scan,
respectively. There was 100% concurrence between echo-
cardiography and cardiac magnetic resonance for maximal
LVWT measurements in all black athletes with LVH.
Discussion
Recent studies indicate that black male athletes exhibit a
higher prevalence of LVH and repolarization changes than
white male athletes.10,11,31,32 The present study is the first
to specifically examine the adaptive changes in response to
exercise in female international African/Afro-Caribbean
athletes and is of particular clinical relevance because
black female athletes form an increasing population of
high-profile international competitors in the Western
world. Compared with the largest published study in white
female athletes (n5600),8 only 240 black females were
studied; however, when one considers that black female
athletes currently constitute fewer than 10% of all athletes
participating at the national level in the United Kingdom
and France, the study cohort represents a sizeable propor-
tion of athletes available for comparisons and inferences.
Figure 2. Pie charts comparing ECG
anomalies between black athletes and
white athletes. Black athletes exhibited a
higher prevalence of ST-segment eleva-
tion and T-wave inversions than white
athletes. LAE indicates voltage criterion
for left atrial enlargement; RAE, voltage
criterion for right atrial enlargement; LVH
volt, voltage criterion for LVH; ST Elev,
ST-segment elevation; and Inv T, T-wave
inversion.
Figure 3. Spectra of ECG observations
in black athletes revealing Sokolow-Lyon
voltage criteria for LVH and elevated J
point in the lateral leads (A), partial right
bundle-branch block with accompanying
convex ST-segment elevation in leads V1
through V3 (B), and convex ST-segment
elevation and deep T-wave inversions in
leads V1 through V3 (C).
1082 Circulation March 9, 2010
 by guest on November 27, 2013http://circ.ahajournals.org/Downloaded from 
Black Athletes With LVH
As with black male athletes,10 highly trained female athletes
of African/Afro-Caribbean descent demonstrated a greater
maximal LVWT and LVM than white athletes of similar age,
size, and sporting discipline. Consistent with previous re-
ports, none of the white athletes exhibited an LVWT
.11 mm.4,5,6,9 In contrast, 8 black athletes (3%) demonstrated
a maximal LVWT .11 mm (12 to 13 mm) that could have
been consistent with morphologically mild HCM. None of the
8 black athletes revealed any further phenotypic features of
HCM on further clinical evaluation (Table 3).33 Importantly,
because none of the black athletes exhibited an LVWT
.13 mm, it would be reasonable to infer that an absolute
maximal LVWT of 13 mm probably represents the physiologi-
cal upper limit of LVH in an asymptomatic black athlete outside
the context of a family history of HCM, and an LVWT .13 mm
may be considered to represent pathological LVH.
Black athletes with LVH participated in basketball, foot-
ball, judo, netball, sprinting, and wrestling, sports that are not
traditionally associated with physiological LVH in white
athletes, which indicates that the isotonic and isometric
stresses of sport induce more cardiac hypertrophy in black
athletes than in white athletes. Direct comparisons could not
be made in sporting disciplines characteristically associated
with a greater LVWT in whites, such as rowing, canoeing,
and cycling,4–6 because black female athletes in the United
Kingdom and France do not usually excel in such sporting
disciplines. Nevertheless, none of the studies in white women
participating in these sporting disciplines have reported an
LVWT .11 mm.4–6,8,9
Differences in Repolarization Changes Between
Black Athletes and White Athletes
Black female athletes exhibited a greater prevalence of T-wave
inversions than white athletes. T-wave inversions were confined
to V1 through V3 and did not appear to be determined by age,
body size, sporting discipline, or cardiac dimensions. In partic-
ular, athletes with T-wave inversions did not reveal any pheno-
typic features of HCM33 or arrhythmogenic right ventricular
cardiomyopathy34 on subsequent evaluation.
The prevalence and magnitude of these electric changes
remain significantly lower than those observed among black
male athletes10 but higher than those reported in white male
athletes.2,3 Although the relative risk of sudden cardiac death
during sport in women is considerably lower than in men,
female athletes are not exempt from cardiac fatalities during
sport35–37; therefore, the observation that normal healthy
black female athletes may demonstrate physiological LVH
.11 mm and T-wave inversions that mimic morphologically
mild HCM is a major finding and has potential implications
in relation to preparticipation cardiovascular screening pro-
grams.38 However, unlike HCM, none of the black athletes in
the present study exhibited deep T-wave inversions in the
inferior or lateral leads; therefore, the identification of deep
T-wave inversions in these leads in a black female with LVH
may be representative of pathology rather than physiology.
Potential Mechanisms for Ethnic Differences in
Electric and Structural Cardiac Manifestations
The precise mechanisms for the exaggerated myocardial
hypertrophy and ECG appearances in black athletes in re-
sponse to exercise are yet to be elucidated. There may be
racial and gender differences in response to the modulations
in BP that occur during systematic training; however, our
own experience of exercising male black and white athletes
with LVH has not demonstrated any significant differences in
exercise-related BP responses between the ethnic groups.10
Racial and gender differences in large-artery structure and
function,39 endothelial function,40 the renin-angiotensin sys-
tem,41 and levels of vasoactive cytokines42 are recognized and
may partially explain the differences in the magnitude of
LVH between black athletes and white athletes and the
greater predilection to LVH in male athletes in both ethnic
groups, respectively. Recent in vitro and animal studies
indicate that physiological LVH is mediated by the effects of
insulin-like growth factor 143 on the phosphatidylinsitol-3-
kinase–Akt144 pathway, which appears to regulate down-
stream transcription factor and gene product production.45 It
is possible that potential race-related polymorphisms in the
function of insulin-like growth factor 1 within the African
population may also provide an explanation for the greater
magnitude of LVH observed in black athletes.
It is historically recognized that a significant proportion of
normal black men and women exhibit T-wave inversions in
the right precordial leads extending to V3 and V4.46,47 Our
own experience also suggests that black athletes may acquire
such T-wave inversions in the right precordial leads during
physical training (Figure 2) that are not related to cardiac
structure and that regress after a 6- to 8-week period of
deconditioning. Alterations in autonomic cardiac innervation,
either reduced sympathetic or increased vagal tone, or re-
cently identified sodium channel polymorphisms among the
black population48 may provide some explanation for the
variation found within black athletes; however, more detailed
molecular assessment and longitudinal follow-up of black
athletes is necessary to unravel the intriguing manifestations
of the black athlete’s heart.
The authors recognize that misuse of performance-
enhancing substances may be associated with LVH and
marked repolarization changes49; however, all athletes stud-
ied were part of national and international squads and as such
underwent regular testing for the presence of such substances.
Hence, all subjects were considered free from compounds
that could have adversely affected the results of the present
study.
Conclusions
Systematic physical exercise in black female athletes is
associated with greater LVH and higher prevalence of repo-
larization changes than in white female athletes of similar age
and size participating in identical sporting disciplines. How-
ever, a maximal LVWT .13 mm or deep T-wave inversions
in the inferior and lateral leads are rare and warrant further
investigation.
Study Limitations
The study exhibits some limitations that warrant mention.
Although a substantial number of black athletes were studied,
a relatively limited number of sporting disciplines were
examined compared with previous studies in whites for
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reasons outlined above. The study was confined to black
athletes competing in the United Kingdom and France, and
although we are confident that our observations are an
accurate representation of black athletes in Europe, caution
must be exercised when our conclusions are extrapolated to
apply to black athletes in other parts of the world. Finally, the
study was cross-sectional in design; therefore, it is possible
that some black athletes exhibiting LVH or marked repolar-
ization abnormalities may have had HCM but were uniden-
tified owing to incomplete expression of the disease pheno-
type, which calls for longitudinal studies in black athletes
with LVH and/or marked repolarization changes in the future.
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CLINICAL PERSPECTIVE
The investigators provide novel data on physiological cardiac adaptation in highly trained female black athletes. Existing data
relating to ethnic differences in exercise-related cardiovascular adaptation are confined to men and indicate a racial predilection
to the development of substantial left ventricular hypertrophy and marked repolarization changes in black athletes that may
overlap with hypertrophic cardiomyopathy. This study of 240 normotensive, nationally ranked black female athletes and 200
nationally ranked white athletes participating in 10 different sporting disciplines reveals that black women also exhibit greater
magnitude of left ventricular hypertrophy and higher prevalence of repolarization anomalies than their white counterparts. Three
percent of black athletes showed a left ventricular wall thickness .11 mm (12 to 13 mm) compared with none of the white
athletes, and almost 15% demonstrated repolarization changes, including deep T-wave inversions, compared with only 2% of
white athletes. In contrast to most individuals with hypertrophic cardiomyopathy, none of the black athletes exhibited a left
ventricular wall thickness .13 mm or deep T-wave inversions in contiguous inferior/lateral leads, which indicates that such
observations in black female athletes warrant further investigation. Application of standardized criteria derived from white
athletes for differentiation of physiological adaptation from hypertrophic cardiomyopathy has the potential to result in
unnecessary investigation and unfair disqualification from sport in black athletes. The study is clinically relevant in facilitating
the differentiation of physiological adaptation from morphologically mild hypertrophic cardiomyopathy in black female athletes
exhibiting left ventricular hypertrophy, particularly in countries where black individuals represent a high proportion of athletes
competing at regional and national levels.
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